Organization type
- Private research organization
Early phases
- Biomarker identification
-
Omics
- Target identification – new biological hypothesis
- Target validation – Hypothesis verification
Screening
-
Assay development
- In vitro screening models
-
Chemical libraries
- Natural product extracts: plants, microbial, animal (invertebrates, insects)
- Small molecules (including natural product, DNA encoded libraries and fragment libraries)
- Screening and high throughput screening using small molecules (including natural product, DNA encoded libraries and fragment libraries)
Optimization phases
- In vitro biochemical models(including assay/model development and testing)
- In vitro cellular and organotypic 3D models (including assay/model development and testing)
-
Mechanism of action (MoA) assessment
- Functional cellular panels
- Target deconvolution
Functional areas
- Bioinformatics
- Compound management
- Material / reagents supply
-
Molecular and cellular biology
- Cell line generation
- Imaging / High content screening
- Protein expression / purification
- RNAseq
Terapeutic areas
- Cancer
- Infectious diseases
- Nervous Central System
- Rare diseases